Pharmaceutical Executive: January 2023

January 11, 2023

What the c-suite should consider in today’s marketplace.

January 11, 2023

The parameters governing pharma promotional speech in digital and social media have struggled to keep pace with the rapidly evolving healthcare communications landscape. How can FDA play catch-up in advancing an agenda more reflective of industry and patient needs?

January 11, 2023

As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.

January 11, 2023

As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.

January 11, 2023

Pharma companies are teaming with academic institutions earlier in the R&D process.

January 11, 2023

Interpreting what the Inflation Reduction Act could mean for biopharma.

January 11, 2023

How technology will play a big role in advancing pharma approaches in patient support.

January 11, 2023

As new channels enter healthcare conversation mix, engagement strategies are changing.

January 11, 2023

An evolving job market has forced life sciences companies to respond.

January 11, 2023

The steps companies can take now to better protect themselves and their data.

January 11, 2023

Exploring the most relevant topics affecting the biopharma industry as the new year gets underway—ranging from trends ripe with risk and opportunity to those driving more definitive growth opportunities in patient care.

January 11, 2023

Natalie Bickford, chief people officer at Sanofi, reveals how she approaches the employee experience, which ultimately influences employee retention, and discusses the importance of a corporate DE&I strategy in those efforts.

January 11, 2023

What a changing economy and related trends could mean for 2023.

January 11, 2023

Supporting health plan clinical preparation and financial modeling.

January 11, 2023

An ecosystem perspective is the first step.

January 11, 2023

Member states air concerns over excess supplies of COVID vaccines.

January 11, 2023

2023 is poised to deliver a new set of challenges.

January 11, 2023

Pharm Exec introduces new managing editor.

January 11, 2023

Click the title above for a link to open the Pharmaceutical Executive January 2023 issue in an interactive PDF format.